Sight Sciences to Participate in the Upcoming Piper Sandler Annual Healthcare Conference

NEXT STORY
GENFIT: FNIH NIMBLE Study Demonstrates NIS4® Technology’s Unique Performance in Identifying Patients with “at-risk” NASH
PREV STORY
Connect Biopharma Reports Positive Top-Line Results from the Global Phase 2 Clinical Trial of CBP-201 in Patients with Moderate-to-Severe Atopic Dermatitis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SCYNEXIS to Present Clinical Data from Ongoing FURI and CARES Studies at the 10th Trends in Medical Mycology Meeting Showing Oral Ibrexafungerp Provides a Favorable Therapeutic Response in Patients with Severe Fungal Infections

author_avatar
NASDAQ Market News

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Cannabidiol Oral Solution in Lennox-Gastaut Syndrome

– First dose-ranging study comparing pharmaceutical formulation of cannabidiol to placebo as add-on therapy in ...

author_avatar
NASDAQ Market News

CorMedix Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on November 5

author_avatar
NASDAQ Market News